Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

NTI drugs with moderate to high variability [Regulatives / Guidelines]

posted by arl_stat – India, 2015-12-10 07:53 (3854 d 01:51 ago) – Posting: # 15714
Views: 4,906

Hello Everyone.

Greetings!!!

The BE criteria for NTI drugs is 90-111%. It is expected to have a low variability for NTI drugs.
What is the BE criteria for known NTI drugs who possess moderate to high variability?

Thank you.

Complete thread:

NTI drugs with moderate to high variabilityarl_stat 2015-12-10 06:53
- NTI drugs with moderate to high variability d_labes 2015-12-10 08:47
  - NTI drugs with moderate to high variability arl_stat 2015-12-14 06:00

Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
242 visitors (0 registered, 242 guests [including 19 identified bots]).
Forum time: 10:44 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas. Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz